查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
全球医疗外骨骼市场——规模、份额、趋势分析、机会和预测：按类型、流动性别、组件、应用和地区划分（2019-2029 年）
市场调查报告书
商品编码
1249969

全球医疗外骨骼市场——规模、份额、趋势分析、机会和预测：按类型、流动性别、组件、应用和地区划分（2019-2029 年）

Medical Exoskeleton Market - Global Size, Share, Trend Analysis, Opportunity and Forecast Report, 2019-2029, Segmented By Type ; By Mobility ; By Component ; By Application ; By Region
出版日期: | 出版商: Blueweave Consulting | 英文 400 Pages | 商品交期: 2-3个工作天内

价格
简介目录

到 2029 年，全球医疗外骨骼市场规模将从 2022 年的 3.2762 亿美元达到 20.724 亿美元，在 2023-2029 年的预测期内以 30.2% 的复合年增长率增长。预计健康增长。 市场的主要增长因素是世界人口老龄化加剧，医疗设备在汽车、军事和国防、建筑等各个行业的使用不断增加，以及中风发病率上升。

本报告研究和分析全球医疗外骨骼市场，提供市场规模和预测、细分市场分析、区域分析、公司概况等。

内容

第一章研究框架

第 2 章执行摘要

第三章全球医疗外骨骼市场回顾

  • 应用价值链分析
  • DROC 分析
    • 司机
    • 约束因素
    • 机会
    • 任务
  • 技术进步/最新发展
  • 监管框架
  • 波特的五力分析

第 4 章全球医疗外骨骼市场概述

  • 市场规模和预测（2019-2029 年）
    • 数量
  • 市场份额和预测
    • 按类型
      • 动力外骨骼
      • 被动外骨骼
    • 流动性别
      • 固定类型
      • 可移动
    • 按组件
      • 硬件
      • 软件
    • 通过使用
      • 脊髓损伤
      • 中风
      • 其他
    • 按地区
      • 北美
      • 欧洲
      • 亚太地区
      • 拉丁美洲
      • 中东和非洲

第五章北美医用外骨骼市场

  • 市场规模和预测（2019-2029 年）
    • 数量
  • 市场份额和预测
    • 按类型
    • 流动性别
    • 按组件
    • 通过使用
    • 按国家
      • 美国
      • 加拿大

第 6 章欧洲医用外骨骼市场

  • 市场规模和预测（2019-2029 年）
    • 数量
  • 市场份额和预测
    • 按类型
    • 流动性别
    • 按组件
    • 通过使用
    • 按国家
      • 德国
      • 英国
      • 意大利
      • 法国
      • 西班牙
      • 比利时
      • 俄罗斯
      • 荷兰
      • 其他欧洲

第七章亚太医用外骨骼市场

  • 市场规模和预测（2019-2029 年）
    • 数量
  • 市场份额和预测
    • 按类型
    • 流动性别
    • 按组件
    • 通过使用
    • 按国家
      • 中国
      • 印度
      • 日本
      • 韩国
      • 澳大利亚和新西兰
      • 印度尼西亚
      • 马来西亚
      • 新加坡
      • 越南
      • 亚太其他地区

第八章拉丁美洲医用外骨骼市场

  • 市场规模和预测（2019-2029 年）
    • 数量
  • 市场份额和预测
    • 按类型
    • 流动性别
    • 按组件
    • 通过使用
    • 按国家
      • 巴西
      • 墨西哥
      • 阿根廷
      • 秘鲁
      • 其他拉丁美洲

第9章中东和非洲医用外骨骼市场

  • 市场规模和预测（2019-2029 年）
    • 数量
  • 市场份额和预测
    • 按类型
    • 流动性别
    • 按组件
    • 通过使用
    • 按国家
      • 沙特阿拉伯
      • 阿拉伯联合酋长国
      • 卡塔尔
      • 科威特
      • 南非
      • 尼日利亚
      • 阿尔及利亚
      • 其他中东和非洲地区

第10章竞争格局

  • 主要公司及其类型列表
  • 全球医用外骨骼企业市场份额分析（2022年）
  • 竞争基准：按管理参数
  • 重大战略发展（合併、收购、合作等）

第 11 章 COVID-19 对全球医用外骨骼市场的影响

第12章公司概况（公司概况、财务矩阵、竞争格局、主要人力资源、主要竞争对手、联繫人、战略前景、SWOT分析）

  • Ekso Bionics
  • ReWalk Robotics
  • PARKER HANNIFIN CORP
  • CYBERDYNE INC.
  • BIONIK
  • Rex Bionics Ltd.
  • B-Temia
  • Bioventus
  • Hocoma
  • Wearable Robotics srl
  • ExoAtlet
  • Meditouch
  • Suit X
  • MarsiBionics
  • Rehab-Robotics Company Limited
  • Myomo Inc.
  • 其他知名公司

第 13 章关键战略建议

第 14 章研究方法论

简介目录
Product Code: BWC23215

Global Medical Exoskeleton Market Size Zooming More Than 6X to Reach USD 2.1 Billion by 2029.

Global medical exoskeleton market is flourishing because of rapid adoption of technology advancements to address the healthcare need of aging world population and people with physical disabilities.

BlueWeave Consulting, a leading strategic consulting and market research firm, in its recent study, estimated global medical exoskeleton market size at USD 327.62 million in 2022. During the forecast period between 2023 and 2029, BlueWeave expects global medical exoskeleton market size to grow at a robust CAGR of 30.2% reaching a value of USD 2,072.40 million by 2029. Major growth factors of global medical exoskeleton market include growing elderly population across the world, rising rates of medical device utilization in various industries, such as automobile, military, defense, and construction, and increasing stroke incidences. The growing number of patients with physical disabilities worldwide will drive the medical exoskeleton market. The number of people with physical disabilities is rapidly increasing as a result of car accidents, strokes, and serious injuries, which should encourage the market growth. Strokes are more common in the elderly population. According to the United States Census Bureau, the number of Americans aged 65 and up will more than double by 2050, which could boost the demand for medical exoskeleton across the countries. As a result, the demand for rehabilitation is expected to fuel the growth of the medical exoskeleton market. Also, the increasing prevalence of spinal cord injuries (SCI) is likely to increase demand across the global market during the forecast period. However, regulatory challenges for securing approvals for medical is anticipated to restrain the global medical exoskeleton market during the period in analysis.

Global Medical Exoskeleton Market - Overview:

Robotics is an application of engineering aimed at replacing humans with menial duties, whereas exoskeletons are applications of robotics and bio-mechatronics aimed at augmenting humans while performing a variety of tasks. A robotic suit, powered armor, wearable machine, power jacket, and exo-frame or suit are all synonyms for the exoskeleton. The field of exoskeleton systems is constantly evolving in the current context. Exoskeletons are employed in a variety of industries, including military, civilian, and rehabilitation, to boost soldiers' travel and loading capacities, to strengthen an operator's load-handling capabilities, and to improve lost functionality and patient life. It is also used to treat musculoskeletal diseases. It aids physical therapists in training individuals with motor nerve degeneration and motor cognitive limitations. Exoskeletons are also used in rehabilitation, particularly inpatient training and movement. Wearable exoskeletons are gaining popularity due to the high need for assistive technology in the medical profession, specifically to address concerns about an aging society. Other medical issues, such as aiding trauma victims, paraplegics, spinal cord injured individuals, and rehabilitation, are also important.

Impact of COVID-19 on Global Medical Exoskeleton Market

COVID-19 pandemic adversely affected the worldwide economy, disrupting supply and demand chains and increasing unemployment rates, resulting in overall economic uncertainty. According to Ekso Bionics' 2020 annual report, revenue income decreased by 36% in FY2020 compared to FY2019 due to a substantial reduction in medical device sales. Furthermore, according to the annual report, the demand for exoskeleton-related items dropped by 38% at the start of the pandemic, resulting in 61 bookings in 2020 as opposed to 98 bookings in 2019. Also, the pandemic led to a shortage of healthcare workers, which has made it difficult for hospitals and clinics to implement medical exoskeletons that require trained personnel to operate. However, the pandemic had a positive impact due to a surge in the number of patients with respiratory issues, and medical exoskeletons were used to support their respiratory function. Also, the rising emphasis on telemedicine influenced the medical exoskeleton market. As the pandemic limited in-person consultations, telemedicine has developed as an important method for healthcare practitioners to give care remotely. As a result, there was a demand for medical exoskeletons that may be used in telemedicine consultations. Hence, medical exoskeletons with remote monitoring and control capabilities have become increasingly popular.

Global Medical Exoskeleton Market - By Type:

By type, global medical exoskeleton market is bifurcated into Powered Exoskeleton and Passive Exoskeleton segments. The powered exoskeleton segment dominated the exoskeleton market in 2022 owing to the increasing use of powered exoskeleton solutions in numerous industries to improve personal safety and productivity. Furthermore, the advantages of powered technology items include smoother lifting motion, less strain on the worker's body, higher strength, force multiplier, and increased productivity.

Competitive Landscape

Major players operating in global medical exoskeleton market include Ekso Bionics, ReWalk Robotics, PARKER HANNIFIN CORP, CYBERDYNE INC., BIONIK, Rex Bionics Ltd., B-Temia, Bioventus, Hocoma, Wearable Robotics srl, ExoAtlet, Meditouch, Suit X, MarsiBionics, Rehab-Robotics Company Limited, and Myomo Inc. To further enhance their market share, these companies employ various strategies, including mergers and acquisitions, partnerships, joint ventures, license agreements, and new product launches.

The in-depth analysis of the report provides information about growth potential, upcoming trends, and statistics of Global Medical Exoskeleton Market. It also highlights the factors driving forecasts of total market size. The report promises to provide recent technology trends in Global Medical Exoskeleton Market and industry insights to help decision-makers make sound strategic decisions. Furthermore, the report also analyzes the growth drivers, challenges, and competitive dynamics of the market.

Table of Contents

1. Research Framework

  • 1.1. Research Objective
  • 1.2. Product Overview
  • 1.3. Market Segmentation

2. Executive Summary

3. Global Medical Exoskeleton Market Insights

  • 3.1. Application Value Chain Analysis
  • 3.2. DROC Analysis
    • 3.2.1. Growth Drivers
      • 3.2.1.1. Increasing Number of People with Physical Disabilities
      • 3.2.1.2. Advancement in Technology
    • 3.2.2. Restraints
      • 3.2.2.1. Regulatory Challenges for Securing Approvals for Medical Exoskeletons
    • 3.2.3. Opportunities
      • 3.2.3.1. Introduction of Soft Actuators
    • 3.2.4. Challenges
      • 3.2.4.1. High Equipment Cost
  • 3.3. Technology Advancements/Recent Developments
  • 3.4. Regulatory Framework
  • 3.5. Porter's Five Forces Analysis
    • 3.5.1. Bargaining Power of Suppliers
    • 3.5.2. Bargaining Power of Buyers
    • 3.5.3. Threat of New Entrants
    • 3.5.4. Threat of Substitutes
    • 3.5.5. Intensity of Rivalry

4. Global Medical Exoskeleton Market Overview

  • 4.1. Market Size & Forecast, 2019-2029
    • 4.1.1. By Value (USD Million)
  • 4.2. Market Share & Forecast
    • 4.2.1. By Type
      • 4.2.1.1. Powered Exoskeleton
      • 4.2.1.2. Passive Exoskeleton
    • 4.2.2. By Mobility
      • 4.2.2.1. Stationary
      • 4.2.2.2. Mobile
    • 4.2.3. By Component
      • 4.2.3.1. Hardware
      • 4.2.3.2. Software
    • 4.2.4. By Application
      • 4.2.4.1. Spinal Cord Injury
      • 4.2.4.2. Stroke
      • 4.2.4.3. Others
    • 4.2.5. By Region
      • 4.2.5.1. North America
      • 4.2.5.2. Europe
      • 4.2.5.3. Asia Pacific (APAC)
      • 4.2.5.4. Latin America (LATAM)
      • 4.2.5.5. Middle East and Africa (MEA)

5. North America Medical Exoskeleton Market

  • 5.1. Market Size & Forecast, 2019-2029
    • 5.1.1. By Value (USD Million)
  • 5.2. Market Share & Forecast
    • 5.2.1. By Type
    • 5.2.2. By Mobility
    • 5.2.3. By Component
    • 5.2.4. By Application
    • 5.2.5. By Country
      • 5.2.5.1. United States
      • 5.2.5.1.1. By Type
      • 5.2.5.1.2. By Mobility
      • 5.2.5.1.3. By Component
      • 5.2.5.1.4. By Application
      • 5.2.5.2. Canada
      • 5.2.5.2.1. By Type
      • 5.2.5.2.2. By Mobility
      • 5.2.5.2.3. By Component
      • 5.2.5.2.4. By Application

6. Europe Medical Exoskeleton Market

  • 6.1. Market Size & Forecast, 2019-2029
    • 6.1.1. By Value (USD Million)
  • 6.2. Market Share & Forecast
    • 6.2.1. By Type
    • 6.2.2. By Mobility
    • 6.2.3. By Component
    • 6.2.4. By Application
    • 6.2.5. By Country
      • 6.2.5.1. Germany
      • 6.2.5.1.1. By Type
      • 6.2.5.1.2. By Mobility
      • 6.2.5.1.3. By Component
      • 6.2.5.1.4. By Application
      • 6.2.5.2. United Kingdom
      • 6.2.5.2.1. By Type
      • 6.2.5.2.2. By Mobility
      • 6.2.5.2.3. By Component
      • 6.2.5.2.4. By Application
      • 6.2.5.3. Italy
      • 6.2.5.3.1. By Type
      • 6.2.5.3.2. By Mobility
      • 6.2.5.3.3. By Component
      • 6.2.5.3.4. By Application
      • 6.2.5.4. France
      • 6.2.5.4.1. By Type
      • 6.2.5.4.2. By Mobility
      • 6.2.5.4.3. By Component
      • 6.2.5.4.4. By Application
      • 6.2.5.5. Spain
      • 6.2.5.5.1. By Type
      • 6.2.5.5.2. By Mobility
      • 6.2.5.5.3. By Component
      • 6.2.5.5.4. By Application
      • 6.2.5.6. Belgium
      • 6.2.5.6.1. By Type
      • 6.2.5.6.2. By Mobility
      • 6.2.5.6.3. By Component
      • 6.2.5.6.4. By Application
      • 6.2.5.7. Russia
      • 6.2.5.7.1. By Type
      • 6.2.5.7.2. By Mobility
      • 6.2.5.7.3. By Component
      • 6.2.5.7.4. By Application
      • 6.2.5.8. The Netherlands
      • 6.2.5.8.1. By Type
      • 6.2.5.8.2. By Mobility
      • 6.2.5.8.3. By Component
      • 6.2.5.8.4. By Application
      • 6.2.5.9. Rest of Europe
      • 6.2.5.9.1. By Type
      • 6.2.5.9.2. By Mobility
      • 6.2.5.9.3. By Component
      • 6.2.5.9.4. By Application

7. Asia-Pacific Medical Exoskeleton Market

  • 7.1. Market Size & Forecast, 2019-2029
    • 7.1.1. By Value (USD Million)
  • 7.2. Market Share & Forecast
    • 7.2.1. By Type
    • 7.2.2. By Mobility
    • 7.2.3. By Component
    • 7.2.4. By Application
    • 7.2.5. By Country
      • 7.2.5.1. China
      • 7.2.5.1.1. By Type
      • 7.2.5.1.2. By Mobility
      • 7.2.5.1.3. By Component
      • 7.2.5.1.4. By Application
      • 7.2.5.2. India
      • 7.2.5.2.1. By Type
      • 7.2.5.2.2. By Mobility
      • 7.2.5.2.3. By Component
      • 7.2.5.2.4. By Application
      • 7.2.5.3. Japan
      • 7.2.5.3.1. By Type
      • 7.2.5.3.2. By Mobility
      • 7.2.5.3.3. By Component
      • 7.2.5.3.4. By Application
      • 7.2.5.4. South Korea
      • 7.2.5.4.1. By Type
      • 7.2.5.4.2. By Mobility
      • 7.2.5.4.3. By Component
      • 7.2.5.4.4. By Application
      • 7.2.5.5. Australia & New Zealand
      • 7.2.5.5.1. By Type
      • 7.2.5.5.2. By Mobility
      • 7.2.5.5.3. By Component
      • 7.2.5.5.4. By Application
      • 7.2.5.6. Indonesia
      • 7.2.5.6.1. By Type
      • 7.2.5.6.2. By Mobility
      • 7.2.5.6.3. By Component
      • 7.2.5.6.4. By Application
      • 7.2.5.7. Malaysia
      • 7.2.5.7.1. By Type
      • 7.2.5.7.2. By Mobility
      • 7.2.5.7.3. By Component
      • 7.2.5.7.4. By Application
      • 7.2.5.8. Singapore
      • 7.2.5.8.1. By Type
      • 7.2.5.8.2. By Mobility
      • 7.2.5.8.3. By Component
      • 7.2.5.8.4. By Application
      • 7.2.5.9. Vietnam
      • 7.2.5.9.1. By Type
      • 7.2.5.9.2. By Mobility
      • 7.2.5.9.3. By Component
      • 7.2.5.9.4. By Application
      • 7.2.5.10. Rest of APAC
      • 7.2.5.10.1. By Type
      • 7.2.5.10.2. By Mobility
      • 7.2.5.10.3. By Component
      • 7.2.5.10.4. By Application

8. Latin America Medical Exoskeleton Market

  • 8.1. Market Size & Forecast, 2019-2029
    • 8.1.1. By Value (USD Million)
  • 8.2. Market Share & Forecast
    • 8.2.1. By Type
    • 8.2.2. By Mobility
    • 8.2.3. By Component
    • 8.2.4. By Application
    • 8.2.5. By Country
      • 8.2.5.1. Brazil
      • 8.2.5.1.1. By Type
      • 8.2.5.1.2. By Mobility
      • 8.2.5.1.3. By Component
      • 8.2.5.1.4. By Application
      • 8.2.5.2. Mexico
      • 8.2.5.2.1. By Type
      • 8.2.5.2.2. By Mobility
      • 8.2.5.2.3. By Component
      • 8.2.5.2.4. By Application
      • 8.2.5.3. Argentina
      • 8.2.5.3.1. By Type
      • 8.2.5.3.2. By Mobility
      • 8.2.5.3.3. By Component
      • 8.2.5.3.4. By Application
      • 8.2.5.4. Peru
      • 8.2.5.4.1. By Type
      • 8.2.5.4.2. By Mobility
      • 8.2.5.4.3. By Component
      • 8.2.5.4.4. By Application
      • 8.2.5.5. Rest of LATAM
      • 8.2.5.5.1. By Type
      • 8.2.5.5.2. By Mobility
      • 8.2.5.5.3. By Component
      • 8.2.5.5.4. By Application

9. Middle East & Africa Medical Exoskeleton Market

  • 9.1. Market Size & Forecast, 2019-2029
    • 9.1.1. By Value (USD Million)
  • 9.2. Market Share & Forecast
    • 9.2.1. By Type
    • 9.2.2. By Mobility
    • 9.2.3. By Component
    • 9.2.4. By Application
    • 9.2.5. By Country
      • 9.2.5.1. Saudi Arabia
      • 9.2.5.1.1. By Type
      • 9.2.5.1.2. By Mobility
      • 9.2.5.1.3. By Component
      • 9.2.5.1.4. By Application
      • 9.2.5.2. UAE
      • 9.2.5.2.1. By Type
      • 9.2.5.2.2. By Mobility
      • 9.2.5.2.3. By Component
      • 9.2.5.2.4. By Application
      • 9.2.5.3. Qatar
      • 9.2.5.3.1. By Type
      • 9.2.5.3.2. By Mobility
      • 9.2.5.3.3. By Component
      • 9.2.5.3.4. By Application
      • 9.2.5.4. Kuwait
      • 9.2.5.4.1. By Type
      • 9.2.5.4.2. By Mobility
      • 9.2.5.4.3. By Component
      • 9.2.5.4.4. By Application
      • 9.2.5.5. South Africa
      • 9.2.5.5.1. By Type
      • 9.2.5.5.2. By Mobility
      • 9.2.5.5.3. By Component
      • 9.2.5.5.4. By Application
      • 9.2.5.6. Nigeria
      • 9.2.5.6.1. By Type
      • 9.2.5.6.2. By Mobility
      • 9.2.5.6.3. By Component
      • 9.2.5.6.4. By Application
      • 9.2.5.7. Algeria
      • 9.2.5.7.1. By Type
      • 9.2.5.7.2. By Mobility
      • 9.2.5.7.3. By Component
      • 9.2.5.7.4. By Application
      • 9.2.5.8. Rest of MEA
      • 9.2.5.8.1. By Type
      • 9.2.5.8.2. By Mobility
      • 9.2.5.8.3. By Component
      • 9.2.5.8.4. By Application

10. Competitive Landscape

  • 10.1. List of Key Players and Their Types
  • 10.2. Global Medical Exoskeleton Company Market Share Analysis, 2022
  • 10.3. Competitive Benchmarking, By Operating Parameters
  • 10.4. Key Strategic Developments (Mergers, Acquisitions, Partnerships, etc.)

11. Impact of Covid-19 on Global Medical Exoskeleton Market

12. Company Profile (Company Overview, Financial Matrix, Competitive Landscape, Key Personnel, Key Competitors, Contact Address, Strategic Outlook, SWOT Analysis)

  • 12.1. Ekso Bionics
  • 12.2. ReWalk Robotics
  • 12.3. PARKER HANNIFIN CORP
  • 12.4. CYBERDYNE INC.
  • 12.5. BIONIK
  • 12.6. Rex Bionics Ltd.,
  • 12.7. B-Temia
  • 12.8. Bioventus
  • 12.9. Hocoma
  • 12.10. Wearable Robotics srl
  • 12.11. ExoAtlet
  • 12.12. Meditouch
  • 12.13. Suit X
  • 12.14. MarsiBionics
  • 12.15. Rehab-Robotics Company Limited
  • 12.16. Myomo Inc.
  • 12.17. Other Prominent Players

13. Key Strategic Recommendations

14. Research Methodology

  • 14.1. Qualitative Research
    • 14.1.1. Primary & Secondary Research
  • 14.2. Quantitative Research
  • 14.3. Market Breakdown & Data Triangulation
    • 14.3.1. Secondary Research
    • 14.3.2. Primary Research
  • 14.4. Breakdown of Primary Research Respondents, By Region
  • 14.5. Assumptions & Limitations